scispace - formally typeset
J

Jared Streatfeild

Researcher at Deloitte

Publications -  8
Citations -  524

Jared Streatfeild is an academic researcher from Deloitte. The author has contributed to research in topics: Population & Economic cost. The author has an hindex of 7, co-authored 8 publications receiving 231 citations.

Papers
More filters
Journal ArticleDOI

The economic cost of inadequate sleep.

TL;DR: The financial and nonfinancial costs associated with inadequate sleep are substantial and warrant substantial investment in preventive health measures to address the issue through education and regulation.
Journal ArticleDOI

The economic impact of sight loss and blindness in the UK adult population

TL;DR: The large prevalence of sight loss and blindness in the UK population imposes significant costs on public funds, private expenditure, and health, highlighting the need for population-based studies that track the prevalence of Sight-impairing eye conditions and treatment effects over time.
Journal ArticleDOI

Social and economic cost of eating disorders in the United States: Evidence to inform policy action

TL;DR: In this article, the authors estimated one-year costs of eating disorders in the United States from a societal perspective, including the costs to the U.S. health system, individual and family productivity costs, lost wellbeing, and other societal economic costs.
Journal ArticleDOI

Economic impact of delirium in Australia: a cost of illness study.

TL;DR: The findings highlight the substantial burden that delirium imposes on Australian society—both in terms of financial costs associated with health system expenditure and the increased need for residential aged care due to the functional and cognitive decline associated withDelirium and dementia.
Journal ArticleDOI

Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives

TL;DR: These estimates suggest substantial community investment in measures to more systematically identify and treat OSA is justified, apart from potential health and well-being benefits, and financially prudent to do so.